Back to Search
ANITA SABICHI, MD
MD
Medical Oncology Physician
NPI: 1255486924Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
K6284(TX)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
K6284(TX)
Research & Publications (20)
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.
PMID 18172274·Clin Cancer Res·2008
3-trial
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
PMID 16609032·Clin Cancer Res·2006
4-observational
Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression.
PMID 16469639·J Urol·2006
7-preclinical
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
PMID 15533896·Cancer Epidemiol Biomarkers Prev·2004
8-other
COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer.
PMID 15179622·Semin Oncol·2004
6-review
Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
PMID 14555536·Clin Cancer Res·2003
7-preclinical
Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
PMID 12855611·Clin Cancer Res·2003
8-other
COX-2 inhibitors and other NSAIDs in bladder and prostate cancer.
PMID 12795054·Prog Exp Tumor Res·2003
6-review
Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization.
PMID 19572386·Head Neck·2010
5-case
The use of short tandem repeat profiling to characterize human bladder cancer cell lines.
PMID 19375735·J Urol·2009
8-other
Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray.
PMID 18288642·Mol Carcinog·2008
8-other
Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.
PMID 17513803·J Clin Oncol·2007
3-trial
Clinical model of lifetime cost of treating bladder cancer and associated complications.
PMID 16979735·Urology·2006
8-other
15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
PMID 16682954·Oncogene·2006
4-observational
Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
PMID 16391871·Oncol Rep·2006
8-other
RARbeta1': primed to fight retinoid resistance in lung carcinogenesis.
PMID 16288110·J Natl Cancer Inst·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1 Baylor Plz, MS BCM 187
Houston, TX 77030 - Phone
- (713) 798-4508
Quick Facts
- NPI
- 1255486924
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile